(Q46466731)

22 December 2017

title

Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes (English)

1 reference

22 December 2017

0 references

1 reference

Marja-Riitta Taskinen

6

object named as

Marja-Riitta Taskinen

1 reference

22 December 2017

author name string

Anne Hiukka

1

1 reference

22 December 2017

Jamila Fruchart-Najib

2

1 reference

22 December 2017

Eeva Leinonen

3

1 reference

22 December 2017

Hannele Hilden

4

1 reference

22 December 2017

Jean-Charles Fruchart

5

1 reference

22 December 2017

publication date

30 April 2005

1 reference

22 December 2017

published in

Diabetologia

1 reference

22 December 2017

volume

48

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

page(s)

1207-1215

1 reference

22 December 2017

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00125-005-1753-Z

Lipoprotein heterogeneity and apolipoprotein B metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-005-1753-Z

Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-005-1753-Z

Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-005-1753-Z

Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects

21 January 2018

1 reference

12 December 2020

The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients

1 reference

12 December 2020

Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins

1 reference

12 December 2020

Very low density lipoprotein subfractions in Type II diabetes mellitus: alterations in composition and susceptibility to oxidation.

1 reference

12 December 2020

Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

1 reference

12 December 2020

Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.

1 reference

12 December 2020

Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism. Studies before and after sulfonylurea therapy

1 reference

12 December 2020

Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia.

1 reference

12 December 2020

Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in type II diabetes

1 reference

12 December 2020

Apolipoprotein C-II and C-III levels in hyperlipoproteinemia

1 reference

12 December 2020

Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver

1 reference

12 December 2020

Abnormal composition of apoproteins C-I, C-II, and C-III in plasma and very-low-density lipoproteins of non-insulin-dependent diabetic Chinese.

1 reference

12 December 2020

Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensit

1 reference

12 December 2020

Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM.

1 reference

12 December 2020

Composition of very-low-density lipoproteins in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM.

1 reference

12 December 2020

Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration

1 reference

12 December 2020

Important contribution of lipoprotein particle number to plasma triglyceride concentration in type 2 diabetes.

1 reference

12 December 2020

Recycling of apoprotein E is associated with cholesterol efflux and high density lipoprotein internalization.

1 reference

12 December 2020

Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. Etude Cas Témoins sur 'Infarctus du Myocarde.

1 reference

12 December 2020

Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes

1 reference

12 December 2020

The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?

1 reference

12 December 2020

VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial

1 reference

12 December 2020

Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics

1 reference

12 December 2020

Plasma triglyceride level and mortality from coronary heart disease

1 reference

12 December 2020

Modulation of Lipoprotein B Binding to the LDL Receptor by Exogenous Lipids and Apolipoproteins CI, CII, CIII, and E

1 reference

12 December 2020

Do triglycerides provide meaningful information about heart disease risk?

1 reference

12 December 2020

The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]

1 reference

12 December 2020

Apolipoprotein C in type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridaemia

1 reference

12 December 2020

Lipoprotein abnormalities in well-treated type II diabetic patients

1 reference

12 December 2020

Hypertriglyceridemia but not diabetes status is associated with VLDL containing apolipoprotein CIII in patients with coronary heart disease

1 reference

12 December 2020

Heparan sulfate proteoglycans participate in hepatic lipaseand apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins

1 reference

12 December 2020

Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance

1 reference

12 December 2020

Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM

1 reference

12 December 2020

A combination of high concentrations of serum triglyceride and non-high-density-lipoprotein-cholesterol is a risk factor for cardiovascular disease in subjects with abnormal glucose metabolism--The Hoorn Study

1 reference

12 December 2020

A rapid micromethod for apolipoprotein E phenotyping directly in serum

1 reference

12 December 2020

Diabetic dyslipidaemia: from basic research to clinical practice.

1 reference

12 December 2020

Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency

1 reference

12 December 2020

Composition of serum very-low-density and high-density lipoproteins in diabetes

1 reference

12 December 2020

10.1007/S00125-005-1753-Z

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017